Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

被引:662
作者
Cheng, Yuan [1 ,2 ]
He, Cai [1 ,2 ]
Wang, Manni [1 ,2 ]
Ma, Xuelei [1 ,2 ]
Mo, Fei [1 ,2 ]
Yang, Shengyong [1 ,2 ]
Han, Junhong [1 ,2 ]
Wei, Xiawei [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Lab Aging Res & Canc Drug Target, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Natl Clin Res Ctr Geriatr, Chengdu, Sichuan, Peoples R China
关键词
ACUTE MYELOID-LEUKEMIA; CELL LUNG-CANCER; EPITHELIAL-MESENCHYMAL-TRANSITION; TUMOR-SUPPRESSOR GENE; HISTONE DEACETYLASE INHIBITORS; SMALL-MOLECULE INHIBITOR; DE-NOVO METHYLATION; MESSENGER-RNA EXPRESSION; PROTEIN ARGININE METHYLTRANSFERASE; RUBINSTEIN-TAYBI-SYNDROME;
D O I
10.1038/s41392-019-0095-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epigenetic alternations concern heritable yet reversible changes in histone or DNA modifications that regulate gene activity beyond the underlying sequence. Epigenetic dysregulation is often linked to human disease, notably cancer. With the development of various drugs targeting epigenetic regulators, epigenetic-targeted therapy has been applied in the treatment of hematological malignancies and has exhibited viable therapeutic potential for solid tumors in preclinical and clinical trials. In this review, we summarize the aberrant functions of enzymes in DNA methylation, histone acetylation and histone methylation during tumor progression and highlight the development of inhibitors of or drugs targeted at epigenetic enzymes.
引用
收藏
页数:39
相关论文
共 665 条
[11]   Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer [J].
Almeida-Rios, Diogo ;
Graca, Ines ;
Vieira, Filipa Quintela ;
Ramalho-Carvalho, Joao ;
Pereira-Silva, Eva ;
Martins, Ana Teresa ;
Oliveira, Jorge ;
Goncalves, Celine S. ;
Costa, Bruno M. ;
Henrique, Rui ;
Jeronimo, Carmen .
ONCOTARGET, 2016, 7 (33) :53018-53028
[12]   Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy [J].
Amato, Robert J. .
CLINICAL GENITOURINARY CANCER, 2007, 5 (07) :422-426
[13]   HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372 [J].
An, Jiahui ;
Xu, Jie ;
Li, Jiao ;
Jia, Song ;
Li, Xiaonan ;
Lu, Yanan ;
Yang, Yuxin ;
Lin, Zhuojia ;
Xin, Xiaoru ;
Wu, Mengying ;
Zheng, Qidi ;
Pu, Hu ;
Gui, Xin ;
Li, Tianming ;
Lu, Dongdong .
ONCOTARGET, 2017, 8 (30) :49093-49109
[14]   RETRACTED: circZMYM2 Competed Endogenously with miR-335-5p to Regulate JMJD2C in Pancreatic Cancer (Retracted article. See vol. 56, pg. 612, 2022) [J].
An, Yong ;
Cai, Huihua ;
Zhang, Yue ;
Liu, Shengyong ;
Duan, Yunfei ;
Sun, Donglin ;
Chen, Xuemin ;
He, Xiaozhou .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 51 (05) :2224-2236
[15]   Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors [J].
Andricovich, Jaclyn ;
Perkail, Stephanie ;
Kai, Yan ;
Casasanta, Nicole ;
Peng, Weiqun ;
Tzatsos, Alexandros .
CANCER CELL, 2018, 33 (03) :512-+
[16]   CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma [J].
Angel Pavon, Miguel ;
Parreno, Matilde ;
Tellez-Gabriel, Marta ;
Leon, Xavier ;
Arroyo-Solera, Irene ;
Lopez, Montserrat ;
Virtudes Cespedes, Maria ;
Casanova, Isolda ;
Gallardo, Alberto ;
Lopez-Pousa, Antonio ;
Antonia Mangues, Maria ;
Quer, Miquel ;
Barnadas, Agusti ;
Mangues, Ramon .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 :E1392-E1403
[17]   Histone Modifications and Cancer [J].
Audia, James E. ;
Campbell, Robert M. .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2016, 8 (04)
[18]   Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance) [J].
Augert, Arnaud ;
Zhang, Qing ;
Bates, Breanna ;
Cui, Min ;
Wang, Xiaofei ;
Wildey, Gary ;
Dowlati, Afshin ;
MacPherson, David .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (04) :704-713
[19]   PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer [J].
Avasarala, Sreedevi ;
Van Scoyk, Michelle ;
Rathinam, Manoj Kumar Karuppusamy ;
Zerayesus, Sereke ;
Zhao, Xiangmin ;
Zhang, Wei ;
Pergande, Melissa R. ;
Borgia, Jeffrey A. ;
DeGregori, James ;
Port, J. David ;
Winn, Robert A. ;
Bikkavilli, Rama Kamesh .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (21) :13479-13489
[20]   Histone deacetylases: transcriptional repression with SINers and NuRDs [J].
Ayer, DE .
TRENDS IN CELL BIOLOGY, 1999, 9 (05) :193-198